TrialClinical cancer research : an official journal of the American Association for Cancer Research2025

Protein Profiles Predict Treatment Responses to the PI3K Inhibitor Umbralisib in Patients with Chronic Lymphocytic Leukemia.

Yanping Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.